Education
About Us
Working with TipRanks
Follow Us
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Technical Sentiment
Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Inhibikase Therapeutics’s (IKT) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Inhibikase Therapeutics is a Buy.
Inhibikase Therapeutics’s (IKT) 20-Day exponential moving average is 1.65, while Inhibikase Therapeutics’s (IKT) share price is $1.56, making it a Sell.
Inhibikase Therapeutics’s (IKT) 50-Day exponential moving average is 1.66, while Inhibikase Therapeutics’s (IKT) share price is $1.56, making it a Sell.
Inhibikase Therapeutics (IKT) Pivot Points
Classic
1.44
1.49
1.52
1.57
1.60
1.65
1.68
Fibonacci
1.49
1.52
1.54
1.57
1.60
1.62
1.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Inhibikase Therapeutics (IKT) Moving Averages
MA5
1.56Buy
1.58Buy
MA10
1.60Sell
1.60Sell
MA20
1.65Sell
1.65Sell
MA50
1.66Sell
1.66Sell
MA100
1.62Sell
1.67Sell
MA200
1.74Sell
1.80Sell
Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 1.60, while Inhibikase Therapeutics’s (IKT) share price is $1.56, making it a Sell.
Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 1.67, while Inhibikase Therapeutics’s (IKT) share price is $1.56, making it a Sell.
Inhibikase Therapeutics’s (IKT) stock price is $1.56 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 1.66, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.56 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 1.62, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.56 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 1.74, creating a Sell signal.
Inhibikase Therapeutics (IKT) Technical Indicators
RSI (14)
44.30
Neutral
STOCH (9,6)
25.38
Neutral
STOCHRSI (14)
21.65
Neutral
MACD (12,26)
-0.04
Buy
ADX (14)
18.19
Buy
Williams %R
-76.62
Buy
CCI (14)
-96.92
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
37.93
Neutral
ROC
-4.24
Sell
Inhibikase Therapeutics’s (IKT) Relative Strength Index (RSI) is 44.30, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Trend Strength Indicator (ADX) is 18.19, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) Commodity Channel Index (CCI) is -96.92, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Price Rate of Change (ROC) is -4.24, creating a Sell signal.
FAQ
Is IKT a Buy, Hold, or Sell?
Based on IKT’s technical indicators, IKT is a Sell.
What is IKT’s RSI (14)?
IKT’s RSI (14) is 44.30, which suggests IKT is a Neutral.
What is IKT’s MACD?
IKT’s MACD is -0.04, which suggests IKT is a Buy.
What is IKT’s 5-day moving average?
IKT’s 5-day moving average is 1.56, which suggests IKT is a Buy.
What is IKT’s 20-day moving average?
IKT 20-day moving average is 1.65, which suggests IKT is a Sell.
What is IKT’s 50-day moving average?
IKT’s 50-day moving average is 1.66, which suggests IKT is a Sell.
What is IKT’s 200-day moving average?
IKT’s 200-day moving average is 1.74, which suggests IKT is a Sell.
What is IKT’s Williams % R (14)?
IKT’s Williams % R (14) is -76.62, which suggests IKT is a Buy.
What is IKT’s CCI (14)?
IKT’s CCI (14) is -96.92, which suggests IKT is a Neutral.